About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Astrazeneca Pharma India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
308.14
NSE Code
ASTRAZEN
Dividend Yield %
0.35
Market Cap
227861.25
P/E
196.87
EPS
46.30
Face Value
2
BSE
NSE
03-Jul-2025
BSE
NSE
NSE F & O
03-Jul-2025
BSE
NSE
NSE F & O
Last Price
9114.45
Net Change
96.15
% Change
1.07%
Prev.Close
9018.30
Open
9085.00
High
9200.00
Low
9024.70
Volume
2370
Last Price
9111.50
Net Change
99.5
% Change
1.1%
Prev.Close
9012.00
Open
9060.00
High
9205.00
Low
9018.00
Volume
48149
Value
21594314
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
9200.00
52-Week High
10653.05
52-Week Low
6222.35
Value
438549414.5
Best Buy
0.00
Best Sell
9111.50
Best Quantity
0
Sell Quantity
41
Today's Range
9205.00
52-Week High
10691.00
52-Week Low
6220.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
41
Price
9111.50
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
03-Sep-18
10-Sep-18
Dividend
1200 %
05-Jul-24
Company News
30-05-2025
AstraZeneca Pharma gets p...
30-05-2025
AstraZeneca Pharma soars ...
30-05-2025
AstraZeneca Pharma India...
29-05-2025
Astrazeneca Pharma India ...
15-04-2025
AstraZeneca Pharma India ...
15-04-2025
AstraZeneca Pharma surren...
05-04-2025
AstraZeneca Pharma gets n...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.